We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+7.34%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.8B
AUM Growth
+$2.13B
(+17%)
Cap. Flow
+$1.52B
Cap. Flow
% of AUM
10.28%
Top 10 Holdings %
Top 10 Hldgs %
17.14%
Holding
1,089
New
119
Increased
321
Reduced
473
Closed
155
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$132M |
| 2 |
Apple
AAPL
|
+$117M |
| 3 |
Microsoft
MSFT
|
+$100M |
| 4 |
Fidelity National Information Services
FIS
|
+$94.3M |
| 5 |
FedEx
FDX
|
+$91.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$97.2M |
| 2 |
Booking.com
BKNG
|
+$94.2M |
| 3 |
Phillips 66
PSX
|
+$82.9M |
| 4 |
Gilead Sciences
GILD
|
+$73.9M |
| 5 |
Snowflake
SNOW
|
+$51.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.09% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 14.12% |
| 4 | Consumer Discretionary | 11.36% |
| 5 | Industrials | 9.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Ball Corp
BALL
$17.3B
| $27.7M | 0.19% |
541,565
-682,331
| -56% | -$35.3M |
|
152
Avnet
AVT
$7.09B
| $27.5M | 0.19% |
662,272
-367,890
| -36% | -$15.3M |
|
|
MDRX
153
DELISTED
Veradigm Inc. Common Stock
MDRX
| $27.3M | 0.19% |
1,549,998
-40,207
| -3% | -$674K |
|
154
Marriott International
MAR
$100B
| $26.6M | 0.18% |
178,693
+152,518
| +583% | +$23.5M |
|
155
Par Pacific Holdings
PARR
$3.87B
| $26.2M | 0.18% |
1,124,807
-82,531
| -7% | -$1.8M |
|
156
Acadia Pharmaceuticals
ACAD
$4.34B
| $26.1M | 0.18% |
1,639,183
+552,681
| +51% | +$8.64M |
|
157
Ionis Pharmaceuticals
IONS
$9.4B
| $26.1M | 0.18% |
689,721
+177,746
| +35% | +$7.48M |
|
158
Ryman Hospitality Properties
RHP
$8.51B
| $25.7M | 0.17% |
313,680
+145,357
| +86% | +$12.4M |
|
159
Terex
TEX
$7.89B
| $25.5M | 0.17% |
597,545
+231
| +0% | +$9.3K |
|
160
Delek US
DK
$3.85B
| $25.3M | 0.17% |
938,546
-245,351
| -21% | -$7.24M |
|
|
BNY
161
Bank of New York Mellon
BNY
$107B
| $24.6M | 0.17% |
539,751
+100,617
| +23% | +$4.32M |
|
162
Warrior Met Coal
HCC
$4.19B
| $24.4M | 0.16% |
703,266
-16,292
| -2% | -$576K |
|
163
ManpowerGroup
MAN
$2.44B
| $24.2M | 0.16% |
290,239
-62,052
| -18% | -$4.98M |
|
164
Tenable Holdings
TENB
$3.61B
| $23.8M | 0.16% |
623,590
-38,822
| -6% | -$1.42M |
|
165
Ameren
AEE
$31.4B
| $23.3M | 0.16% |
262,590
-21,596
| -8% | -$1.82M |
|
166
Herbalife
HLF
$1.25B
| $23.1M | 0.16% |
1,553,150
-97,119
| -6% | -$1.69M |
|
167
Semtech
SMTC
$11B
| $23M | 0.16% |
803,168
+431,571
| +116% | +$12.2M |
|
168
Pegasystems
PEGA
$4.74B
| $23M | 0.16% |
1,343,976
-31,290
| -2% | -$541K |
|
169
Travel + Leisure Co
TNL
$4.63B
| $23M | 0.16% |
631,890
-1,232
| -0.2% | -$46.2K |
|
170
World Kinect Corp
WKC
$1.96B
| $22.9M | 0.16% |
839,602
-116,989
| -12% | -$3.14M |
|
171
Factset
FDS
$9.45B
| $22.9M | 0.16% |
57,174
-21,396
| -27% | -$9.11M |
|
|
KYNB
172
Kyntra Bio
KYNB
$28.8M
| $22.9M | 0.15% |
57,065
-156
| -0.3% | -$59.8K |
|
173
Huntsman Corp
HUN
$2.13B
| $22.7M | 0.15% |
824,787
-58,264
| -7% | -$1.58M |
|
174
AXIS Capital
AXS
$8.62B
| $22.4M | 0.15% |
413,833
-7,726
| -2% | -$417K |
|
175
Clorox
CLX
$11.7B
| $22.1M | 0.15% |
157,785
-19,803
| -11% | -$2.81M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2022 Portfolio in Review
As of Q4 2022, Jacobs Levy Equity Management held 1,089 positions worth $14.8B, up 17% from $12.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $1.52B of net new capital in Q4 2022, opening 119 new positions and adding to 321 existing holdings. Its largest new stake was Fidelity National Information Services: 1,326,663 shares worth $90M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Booking.com, an estimated $94.2M trimmed.
- Jacobs Levy Equity Management's largest Q4 2022 buy was Fidelity National Information Services: 1,326,663 shares worth $90M.
- Jacobs Levy Equity Management added most to Vertex Pharmaceuticals in Q4 2022, an estimated $132M increase.
- Jacobs Levy Equity Management's biggest Q4 2022 reduction was Booking.com, cutting an estimated $94.2M.
- Jacobs Levy Equity Management fully exited Cigna in Q4 2022, selling an estimated $97.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $14.8B portfolio in Q4 2022.
- Jacobs Levy Equity Management opened 119 new positions and closed 155 in Q4 2022.
- Jacobs Levy Equity Management's portfolio value rose 17% quarter-over-quarter to $14.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2022, filed 14 Feb 2023.